Cargando…

Retraction: Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report

Detalles Bibliográficos
Autores principales:	Berle, Jan Øystein, Løberg, Else-Marie, Fasmer, Ole Bernt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844366/ https://www.ncbi.nlm.nih.gov/pubmed/23962164 http://dx.doi.org/10.1186/1756-0500-6-332

Ejemplares similares

Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report
por: Berle, Jan Øystein, et al.
Publicado: (2013)

Influence of different second generation antipsychotics on the QTc interval: A pragmatic study
por: Olsen, Roy E, et al.
Publicado: (2016)

Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone
por: Johnsen, Erik, et al.
Publicado: (2010)

QTc Prolongation in Patients Acutely Admitted to Hospital for Psychosis and Treated with Second Generation Antipsychotics
por: Johnsen, Erik, et al.
Publicado: (2013)

Distribution of Active and Resting Periods in the Motor Activity of Patients with Depression and Schizophrenia
por: Fasmer, Ole Bernt, et al.
Publicado: (2016)

Graph theory applied to the analysis of motor activity in patients with schizophrenia and depression
por: Fasmer, Erlend Eindride, et al.
Publicado: (2018)

A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models
por: Boyda, Heidi N., et al.
Publicado: (2021)

Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children
por: Bahr, S M, et al.
Publicado: (2015)

Nonlinear Analysis of Motor Activity Shows Differences between Schizophrenia and Depression: A Study Using Fourier Analysis and Sample Entropy
por: Hauge, Erik R., et al.
Publicado: (2011)

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
por: Divac, Nevena, et al.
Publicado: (2014)

Motor Activity in Adult Patients with Attention Deficit Hyperactivity Disorder
por: Fasmer, Ole Bernt, et al.
Publicado: (2015)

Relapse Prevention in Schizophrenia: A Systematic Review and Meta-Analysis of Second-Generation Antipsychotics versus First-Generation Antipsychotics
por: Kishimoto, Taishiro, et al.
Publicado: (2011)

First-generation vs second-generation antipsychotic drugs: The ongoing saga
por: Gupta, Sumeet
Publicado: (2010)

Arterial Stiffness in Patients Taking Second-generation Antipsychotics
por: Fındıklı, Ebru, et al.
Publicado: (2016)

Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
por: Caruso, Giuseppe, et al.
Publicado: (2020)

Designed proteinoid polymers and nanoparticles encapsulating risperidone for enhanced antipsychotic activity
por: Lugasi, L., et al.
Publicado: (2020)

Proteinoid Nanocapsules as Drug Delivery System for Improving Antipsychotic Activity of Risperidone
por: Lugasi, Liroy, et al.
Publicado: (2020)

Efficacy and Tolerability of Second-Generation Antipsychotics in Children and Adolescents With Schizophrenia
por: Kumra, Sanjiv, et al.
Publicado: (2008)

Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics
por: Oh, Jee-Eun, et al.
Publicado: (2012)

Adherence and Continuation of Treatment with First- and Second-generation Antipsychotics in Schizophrenia
por: Warikoo, Nisha, et al.
Publicado: (2014)

Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

Overcoming barriers to monitoring patients taking second-generation antipsychotics
por: Peña, Anita, et al.
Publicado: (2018)

Updating the Comparative Evidence on Second‐Generation Antipsychotic Use With Schizophrenia
por: McDonagh, Marian S., et al.
Publicado: (2020)

Combination treatment with second generation antipsychotics other than clozapine
por: Schmidt-Kraepelin, C.
Publicado: (2021)

Risk of Breast Cancer in Association with the Use of Second-generation Antipsychotics
por: Joo, Sung Woo, et al.
Publicado: (2022)

Factors Influencing the Use of Second-Generation Antipsychotics in Children with Psychosis
por: Ramachandran, Sujith, et al.
Publicado: (2016)

Movement Disorders in Elderly Users of Risperidone and First Generation Antipsychotic Agents: A Canadian Population-Based Study
por: Vasilyeva, Irina, et al.
Publicado: (2013)

Effectiveness of second generation antipsychotics: A systematic review of randomized trials
por: Johnsen, Erik, et al.
Publicado: (2008)

Dysphagia with second-generation antipsychotics: A case report and review of the literature
por: Crouse, Ericka L., et al.
Publicado: (2018)

Neutropenia induced by several second-generation antipsychotics :A case report
por: Zarouf, H., et al.
Publicado: (2023)

Evaluation of oral antipsychotic supplementation of select second-generation long-acting injectable antipsychotics in an acute-care psychiatric setting
por: Alastanos, Jennifer N., et al.
Publicado: (2019)

Blood lactate levels in patients receiving first- or second- generation antipsychotics
por: Glavina, Trpimir, et al.
Publicado: (2011)

Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review
por: Miller, Brian J., et al.
Publicado: (2011)

Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy
por: Jauhar, Sameer, et al.
Publicado: (2019)

Intentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics
por: Klein, Lauren, et al.
Publicado: (2017)

Integrative Management of Metabolic Syndrome in Youth Prescribed Second-Generation Antipsychotics
por: Rice, Jessie, et al.
Publicado: (2020)

Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
por: Grajales, Diana, et al.
Publicado: (2019)

Second-generation antipsychotic use during pregnancy and risk of congenital malformations
por: Ellfolk, Maria, et al.
Publicado: (2021)

Association of Lithium and Second-Generation Antipsychotics with Neurocognition in Youth with Bipolar Disorder
por: Jiang, Xinyue, et al.
Publicado: (2022)

Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
por: Płaza, Olga, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a4g0kcf9o17cm72hr9q6jt8216